Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiwei Tang

Showing results (291-300 of 295) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 295 results.
Light, Science & Applications|February 2, 2026
Polarization-sensitive neuromorphic vision sensing enabled by pristine black arsenic-phosphorusShi Zhang, Shuguang Zhu, Shijian Tian, et al.
Nature Communications|February 2, 2023
Tautomerism unveils a self-inhibition mechanism of crystallizationWeiwei Tang, Taimin Yang, Cristian A Morales-Rivera, et al.
Cell Death Discovery|August 17, 2021
LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancerWeiwei Tang, Kumaraguruparan Ramasamy, Sureshkumar M A Pillai, et al.
Communications Biology|October 30, 2021
LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancerMengxing Li, Suryavathi Viswanadhapalli, Bindu Santhamma, et al.
Journal for Immunotherapy of Cancer|April 5, 2022
Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trialYongxiang Xia, Weiwei Tang, Xiaofeng Qian, et al.
Pageof 30

Showing results (291-300 of 295) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 295 results.
Light, Science & Applications|February 2, 2026
Polarization-sensitive neuromorphic vision sensing enabled by pristine black arsenic-phosphorusShi Zhang, Shuguang Zhu, Shijian Tian, et al.
Nature Communications|February 2, 2023
Tautomerism unveils a self-inhibition mechanism of crystallizationWeiwei Tang, Taimin Yang, Cristian A Morales-Rivera, et al.
Cell Death Discovery|August 17, 2021
LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancerWeiwei Tang, Kumaraguruparan Ramasamy, Sureshkumar M A Pillai, et al.
Communications Biology|October 30, 2021
LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancerMengxing Li, Suryavathi Viswanadhapalli, Bindu Santhamma, et al.
Journal for Immunotherapy of Cancer|April 5, 2022
Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trialYongxiang Xia, Weiwei Tang, Xiaofeng Qian, et al.
Pageof 30